Crescita Therapeutics Inc. (TSX:CTX) agreed to acquire Assets of Occy Laboratory on June 20, 2024.The transaction was approved by the bankruptcy court, is subject only to customary closing conditions, and is expected to close thereafter.

Crescita Therapeutics Inc. (TSX:CTX) completed the acquisition of Assets of Occy Laboratory for CAD 0.9 million on June 26, 2024.